CXCR4 and breast carcinoma: In a mouse model of human breast cancer, these nanoparticles improved the biostability of siRNA and preferentially accumulated at the tumor site due to pH-responsive properties, thus delivering siRNA to the cytoplasm and acting directly on CXCR4 transcripts, thereby significantly inhibiting CXCR4 protein expression in breast cancer cells.